NCT00769704 Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma Status COMPLETED Phase PHASE3
NCT00757172 Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT00757042 Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT00756444 A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE2
NCT00752570 A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma Status COMPLETED Phase PHASE2
NCT00752414 A Phase 1b Study to Evaluate the Safety and PK of MP-376 in Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE1
NCT00739648 A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE2
NCT00724386 Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT00721734 Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function Status COMPLETED Phase PHASE2
NCT00719550 AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00704652 Evaluation of Retinal Changes in Systemic Darbepoetin Alpha Treatment in Patients With Diabetes Mellitus Status TERMINATED Phase N/A
NCT00695370 Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children Status TERMINATED Phase PHASE2
NCT00686335 A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal Asthma Status COMPLETED Phase PHASE2
NCT00682383 Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00680992 Study of Denosumab in Subjects With Giant Cell Tumor of Bone Status COMPLETED Phase PHASE2
NCT00677365 Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients Status COMPLETED Phase PHASE2